HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cancer Genome

Cancer Genome

Cancer genome exploration delves deep into the intricate genetic fabric that underpins cancer's origin and progression. By meticulously dissecting the DNA blueprint within cancerous cells, researchers uncover pivotal mutations dictating tumor growth, spread, and resistance to treatment. This genomic scrutiny not only unveils the diverse molecular mechanisms propelling cancer but also heralds a new era of tailored therapies, finely tuned to the individual genetic makeup of patients. Advanced methodologies such as next-generation sequencing unravel the complexity of various cancer types, offering profound insights into potential therapeutic targets and predictive markers. Initiatives like The Cancer Genome Atlas (TCGA) serve as vast treasure troves of genomic data, fueling collaborative endeavors aimed at unraveling cancer's genomic mysteries and revolutionizing oncology. Through relentless exploration of the cancer genome, scientists endeavor to unearth innovative strategies for early detection, precise intervention, and ultimately, the triumph over cancer's formidable grip.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp